What does the evidence say about Hesperidin Exercise Performance Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Hesperidin Exercise Performance Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Endothelial dysfunction (ED) can lead to a reduced NO availability or an increased ET-1 synthesis, release, or activity [,]. [Imperatrice Maria (2022); evidence level 3] - The main mechanisms underlying the pathophysiology of ED are increased reactive oxygen species (ROS), inflammation and diminished NO production, and bioavailability []. [Imperatrice Maria (2022); evidence level 3] - Therefore, improved muscle perfusion during exercise via vascular endothelial function can positively impact endurance exercise performance. [Imperatrice Maria (2022); evidence level 3] - 1 2 During exercise, skeletal muscle cells convert biological fuel (e.g., lipids, carbohydrates) into mechanical force to allow muscle contraction and therefore movement. [Imperatrice Maria (2022); evidence level 3] - The use of ergogenic aids, particularly polyphenols such as 2S-hesperidin, has gained attention due to their potential to enhance exercise performance, although evidence in team sports and female athletes remains limited. [Flórez-Gil E (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.